IgA nephropathy (IgAN), is a type of kidney disease that can have a serious impact on a person’s life. Learn more about IgAN, how it’s treated, and how to find support.
How is IgAN treated?
Treatment helps protect kidney function and slow the progression of IgAN.
Your Kidney Numbers Help Tell Your IgAN Story
Your test results can help you and your healthcare team understand how well your kidneys are working and whether IgAN is changing over time.
Estimated Glomerular Filtration Rate (eGFR)
Shows how well your kidneys are filtering your blood.
Albuminuria (proteinuria)
Checks for high protein in the urine, which is a sign of kidney damage.
Blood pressure and your kidneys
Keeping blood pressure in a healthy range can help protect your kidneys
Understanding Your IgAN Treatment
Treatment for IgAN may include medicines that protect kidney function, lower protein in your urine, control blood pressure, or target parts of the immune system involved in IgAN.
Managing Treatments with IgAN
Treatment is focused on managing symptoms, managing your blood pressure, and slowing the kidney disease process.
Medicines for IgAN
Learn about medicines used to slow kidney damage and treat the IgAN disease process.
Questions to Ask Your Healthcare Professional: IgAN
Prepare for appointments by asking about your test results, treatment goals, medicines, and next steps.
Eating well with kidney disease
Find nutrition guidance, recipes, and meal-planning resources for kidney health.
Staying Active with Kidney Disease
Learn how regular activity can support strength, energy, blood pressure, and overall health.
Emotional Health and Kidney Disease
Kidney disease can affect how you feel. Find information and support for stress, anxiety, and other emotions.
Help Advance IgAN Research
Living with a rare disease may also bring opportunities to help researchers better understand IgAN and improve future care.
Clinical Trials
Explore kidney disease clinical trial opportunities and talk with your doctor about studies that may be right for you.
KidneyCARE Study
A patient registry for people at all stages and with all types of kidney disease.
Find Clinical Trials
There are multiple clinical trial opportunities and new ones are available throughout the year.
AJKD KDOQI Commentary
KDOQI US Commentary on the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)
Lighting the Fire in IgAN — Time is Nephrons
A webinar series featuring experts discussing IgAN pathophysiology, biomarkers, and the KDIGO 2025 Guideline recommendations for IgAN diagnosis and treatment.
IgAN Clinical Education Series
These programs for healthcare professionals feature experts discussing the impact of IgAN on kidney health and highlighting evidence supporting treatment of the immune-mediated pathogenesis of IgAN.
